Cadila Healthcare informs about press release

18 Nov 2021 Evaluate

Cadila Healthcare has informed that it enclosed a press release dated November 18, 2021, titled ‘Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

890.60 14.25 (1.63%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×